Shares of Compass Therapeutics, Inc. (CMPX) tumbled sharply despite encouraging clinical results.
The stock is currently trading at $1.87, down $3.15 or 62.67%, on the Nasdaq. It opened at $1.76 after closing the previous session at $5.02. The stock has traded between $1.61 and $6.88 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.